Amneal Targets Limited US Ciprodex Pool With FDA Approval
FDA Approval Marks Another Addition To The Firm’s Growing Complex Drug Portfolio
The FDA has granted approval to Amneal’s ciprofloxacin/dexamethasone otic suspension ANDA product, referencing Ciprodex, adding a further drug to the company’s portfolio as the firm continues its strategic shift to complex generics.
